Cite
HARVARD Citation
Tavera, L. et al. (n.d.). BLU-701 tumour suppression and intracranial activity as a single agent and in combination with BLU-945 in models of non-small cell lung cancer (NSCLC) driven by EGFR mutations. Lung cancer. pp. S37-. [Online].